Skip to content
Phlexglobal

Phlexglobal

HealthTech·UK·Exited 2022·Held 6yr
Entry
2016
Hold
6yr
Exit
2022

Who owns Phlexglobal?

Phlexglobal is a British HealthTech company, now owned by PharmaLex, which acquired it in 2022 from Vitruvian Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Vitruvian Partners
Most recent investor
Vitruvian Partners
Vitruvian Investment Partnership II · 2014 · Growth
2 ownership periods · full history below

Key facts

HQUK
SectorHealthTech
Key takeaways
  • ·Fully exited in 2022 to PharmaLex.
  • ·Average hold across 2 realized cycles: 4 years.

Ownership history

2 ownership periods

Exited
Last exited in 2022 to PharmaLex.
Bridgepoint
BridgepointExited 2016
2014 · 2016(2yr) · Europe VII (BE VII) · 2022 · Buyout
Secondary · to Vitruvian Partners

Bridgepoint sold Phlexglobal to Vitruvian Partners in 2016 after 2 years.

Vitruvian Partners
2016 · 2022(6yr) · Vitruvian Investment Partnership II · 2014 · Growth
Trade Sale · to PharmaLex

Vitruvian Partners sold Phlexglobal to PharmaLex in 2022 after 6 years.

Questions

Who owns Phlexglobal?

Phlexglobal is now owned by PharmaLex, which acquired it in 2022 from Vitruvian Partners.

When did PharmaLex acquire Phlexglobal?

PharmaLex acquired Phlexglobal in 2022, buying from Vitruvian Partners.

Who did Phlexglobal sell to?

Vitruvian Partners sold Phlexglobal to PharmaLex in 2022 (Trade Sale). Bridgepoint sold Phlexglobal to Vitruvian Partners in 2016 (Secondary).

Who has owned Phlexglobal over time?

Phlexglobal has been through 2 private-equity ownership periods: Bridgepoint · via Europe VII (BE VII) · 2014–2016 · sold to Vitruvian Partners · (Secondary); Vitruvian Partners · via Vitruvian Investment Partnership II · 2016–2022 · sold to PharmaLex · (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue